Diversified Healthcare Trust (NASDAQ:DHC) Hits New 52-Week High – Time to Buy?

by · The Cerbat Gem

Shares of Diversified Healthcare Trust (NASDAQ:DHCGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $8.88 and last traded at $8.8520, with a volume of 346611 shares traded. The stock had previously closed at $8.58.

Analysts Set New Price Targets

A number of brokerages recently issued reports on DHC. Royal Bank Of Canada increased their target price on shares of Diversified Healthcare Trust from $5.00 to $6.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Freedom Capital raised shares of Diversified Healthcare Trust to a “strong-buy” rating in a research note on Thursday, April 30th. Zacks Research upgraded shares of Diversified Healthcare Trust from a “strong sell” rating to a “hold” rating in a report on Friday, February 20th. Wall Street Zen cut Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Finally, Maxim Group set a $10.00 price target on Diversified Healthcare Trust in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $8.17.

View Our Latest Report on DHC

Diversified Healthcare Trust Price Performance

The company has a market cap of $2.15 billion, a price-to-earnings ratio of -6.69 and a beta of 2.33. The company has a current ratio of 5.36, a quick ratio of 5.36 and a debt-to-equity ratio of 1.48. The business has a 50-day moving average price of $7.49 and a 200 day moving average price of $6.17.

Diversified Healthcare Trust (NASDAQ:DHCGet Free Report) last issued its earnings results on Monday, May 4th. The real estate investment trust reported ($0.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.03). The company had revenue of $366.47 million during the quarter, compared to analyst estimates of $380.18 million. Diversified Healthcare Trust had a negative return on equity of 18.75% and a negative net margin of 21.10%.Diversified Healthcare Trust has set its FY 2026 guidance at 0.520-0.580 EPS. As a group, research analysts expect that Diversified Healthcare Trust will post 0.57 earnings per share for the current fiscal year.

Diversified Healthcare Trust Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 14th. Shareholders of record on Tuesday, April 21st were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.4%. The ex-dividend date was Tuesday, April 21st. Diversified Healthcare Trust’s payout ratio is presently -3.01%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Arini Captial Management Ltd purchased a new stake in shares of Diversified Healthcare Trust in the 4th quarter valued at approximately $14,400,000. Carronade Capital Management LP raised its stake in Diversified Healthcare Trust by 181.9% during the 3rd quarter. Carronade Capital Management LP now owns 4,561,748 shares of the real estate investment trust’s stock valued at $20,117,000 after purchasing an additional 2,943,300 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Diversified Healthcare Trust by 158.9% in the first quarter. Goldman Sachs Group Inc. now owns 3,862,334 shares of the real estate investment trust’s stock valued at $9,270,000 after purchasing an additional 2,370,459 shares in the last quarter. Centersquare Investment Management LLC lifted its holdings in shares of Diversified Healthcare Trust by 123.1% in the fourth quarter. Centersquare Investment Management LLC now owns 3,229,172 shares of the real estate investment trust’s stock valued at $15,661,000 after purchasing an additional 1,781,839 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Diversified Healthcare Trust by 125.1% in the first quarter. Bank of New York Mellon Corp now owns 2,390,413 shares of the real estate investment trust’s stock worth $15,872,000 after buying an additional 1,328,648 shares during the period. 75.98% of the stock is currently owned by institutional investors and hedge funds.

About Diversified Healthcare Trust

(Get Free Report)

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.

Further Reading